7-Azaindole Analogs and Serotonin Agonists for Neurological Disorders
Summary
The USPTO published patent application US20260092034A1 for 7-azaindole analogs as serotonin receptor agonists for treating neurological disorders. Assigned to Kuleon LLC with inventor David Gilles, the application covers both hallucinogenic and non-hallucinogenic compounds. The patent application was filed December 8, 2025, under application number 19412382.
What changed
The USPTO published a patent application for novel 7-azaindole compounds classified under CPC C07D 209/04, covering serotonin receptor agonists with potential therapeutic applications for neurological disorders. The application discloses both hallucinogenic and non-hallucinogenic compounds along with methods of making and using them. Assignee is Kuleon LLC.
Patent applications do not create compliance obligations for third parties. Healthcare and pharmaceutical companies monitoring this space should note this intellectual property filing for competitive intelligence purposes. No action is required unless companies are developing competing compounds in this chemical space, in which case freedom-to-operate analysis may be warranted.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
7-AZAINDOLE ANALOGS AND METHODS OF TREATING NEUROLOGICAL DISORDERS USING THE SAME
Application US20260092034A1 Kind: A1 Apr 02, 2026
Assignee
Kuleon LLC
Inventors
DAVID GILLES
Abstract
Hallucinogenic and non-hallucinogenic serotonin receptor agonists are disclosed herein in addition to methods of making and using the same.
CPC Classifications
C07D 209/04
Filing Date
2025-12-08
Application No.
19412382
Named provisions
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Organic Chemistry (C07D) publishes new changes.